World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
23911
World Ranking
14255
National Ranking
544

Teun van Gelder publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Teun van Gelder sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 511 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Teun van Gelder D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Teun van Gelder sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Teun van Gelder is affiliated with Leiden University Medical Center in the Netherlands and has a focused research career predominantly in the field of Medicine. Their body of work encompasses 284 publications, with a significant emphasis on subfields such as Transplantation, Pediatrics, Perinatology and Child Health, Pharmacology, Oncology, and Family Practice.

Their research topics include:

  • Renal Transplantation Outcomes and Treatments
  • Pharmacological Effects and Toxicity Studies
  • Medication Adherence and Compliance
  • Antibiotics Pharmacokinetics and Efficacy
  • Neurological Complications and Syndromes
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical studies and practices

Teun van Gelder's frequent co-authors include:

  • Dennis A. Hesselink
  • Dirk Jan A. R. Moes
  • Birgit C. P. Koch
  • Brenda C. M. de Winter
  • Patricia M. L. A. van den Bemt

Their publications often appear in established journals in the clinical pharmacology and transplantation domains. The most frequent publication venues are:

  • Therapeutic Drug Monitoring
  • Clinical Pharmacology & Therapeutics
  • British Journal of Clinical Pharmacology
  • Journal of Hypertension
  • Transplantation

Some of the recent papers authored or co-authored by Teun van Gelder include:

  • Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology, 2021, Therapeutic Drug Monitoring
  • Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT), 2020, Critical Care
  • The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial, 2020, BMC Infectious Diseases
  • Risperidone plasma concentrations are associated with side effects and effectiveness in children and adolescents with autism spectrum disorder, 2020, British Journal of Clinical Pharmacology
  • Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics, 2020, American Journal of Transplantation

Best Publications

  • A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

    T van Gelder;L B Hilbrands;Yves Vanrenterghem;W Weimar

  • Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy : Second Consensus Report

    Mercè Brunet;Teun Van Gelder;Anders Åsberg;Vincent Haufroid;Vincent Haufroid

  • Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.

    Dennis A. Hesselink;Reinier M. van Hest;Ron A. A. Mathot;Fred Bonthuis

  • The Effect of Tolerance to Noninherited Maternal HLA Antigens on the Survival of Renal Transplants from Sibling Donors

    W.J. Burlingham;A.P. Grailer;D.M. Heisey;F.H.J. Claas

  • Therapeutic drug monitoring of mycophenolate mofetil in transplantation.

    Teun van Gelder;Yann Le Meur;Leslie M Shaw;Michael Oellerich

  • Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.

    Teun van Gelder;Jochen Klupp;Markus J. Barten;Uwe Christians

  • Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation.

    Dirk R.J. Kuypers;Yannick Le Meur;Marcelo Cantarovich;Michael J. Tredger

  • Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial

    Teun van Gelder;Helio Tedesco Silva;Johan W. de Fijter;Klemens Budde

  • Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group.

    James M. Neuberger;Wolf O. Bechstein;Dirk R.J. Kuypers;Patrizia Burra

  • Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion.

    Leslie M. Shaw;David W. Holt;Michael Oellerich;Bruno Meiser

  • Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective

    Roelof W F van Leeuwen;Teun van Gelder;Ron H J Mathijssen;Frank G A Jansman

  • High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation

    Lennaert C.P. Borra;Joke I. Roodnat;Judith A. Kal;Ron A.A. Mathot

  • Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs

    van Robert Leeuwen;van Robert Leeuwen;D. H. S. Brundel;C. Neef;T. van Gelder

  • Explaining Variability in Mycophenolic Acid Exposure to Optimize Mycophenolate Mofetil Dosing: A Population Pharmacokinetic Meta-Analysis of Mycophenolic Acid in Renal Transplant Recipients

    Reinier M. van Hest;Ron A.A. Mathot;Mark D. Pescovitz;Robert Gordon

  • Proteinuria after renal transplantation affects not only graft survival but also patient survival.

    J. I. Roodnat;P. G. H. Mulder;J. Rischen-Vos;I. C. Van Riemsdijk

  • Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome

    Krista Kuitwaard;Jenny de Gelder;Anne P. Tio-Gillen;Wim C. J. Hop

  • Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes

    Dennis A. Hesselink;Teun van Gelder;Ron H. N. van Schaik;Aggie H. M. M. Balk

  • Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management.

    Nauras Shuker;Teun van Gelder;Dennis A. Hesselink

  • SUCCESSFUL VACCINATION AGAINST VARICELLA ZOSTER VIRUS PRIOR TO KIDNEY TRANSPLANTATION

    A Geel;W Zuidema;T van Gelder;G van Doornum

  • PHARMACOGENETICS AND GENOMICS Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

    Dennis A. Hesselink;Ron H. N. van Schaik;Ilse P. van der Heiden;Marloes van der Werf

Frequent Co-Authors

Willem Weimar
Willem Weimar Erasmus University Rotterdam
Ron H.N. van Schaik
Ron H.N. van Schaik Erasmus University Rotterdam
Dirk Kuypers
Dirk Kuypers KU Leuven
Klemens Budde
Klemens Budde Charité - University Medicine Berlin
Ron H.J. Mathijssen
Ron H.J. Mathijssen Erasmus University Rotterdam
Carla C. Baan
Carla C. Baan Erasmus University Rotterdam
Jan N. M. IJzermans
Jan N. M. IJzermans Erasmus University Rotterdam
Bruno H. Stricker
Bruno H. Stricker Erasmus University Rotterdam
Albert Hofman
Albert Hofman Harvard University
Pierre Marquet
Pierre Marquet University of Limoges

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you consider studying Medicine in the USA, it's helpful to explore alternative online degrees and healthcare career pathways. These flexible options are ideal for students who want to enter the medical field quickly, advance their credentials, or move into specialized roles.

For those interested in pharmaceuticals, the best online pharmacy school programs offer advanced training for future pharmacists. If information management and technology appeal to you, accredited him programs provide expertise in managing medical records and healthcare data, a field that continues to grow in demand.

Students looking for a quicker entry point may want to investigate how much is medical billing and coding school to understand the investment and opportunities in this administrative and technical field. For nurses seeking advancement, online nurse practitioner programs allow for career progression and increased responsibility—all while studying flexibly.

Each of these online pathways offers unique benefits, affordability, and the flexibility to balance your studies with work or other commitments.

Best Scientists Citing Teun van Gelder

Trending Scientists

Recently Published Articles